ETHEX Corporation Issues Voluntary Nationwide Recall Of Prescription Prenatal and Iron Supplements To Wholesale Level

-FDA MedWatch

02/04/2009- ETHEX Corporation, a subsidiary of KV Pharmaceutical Company is issuing a voluntary nationwide recall of the products identified below (all lots within their expiration dates) at a wholesale level. The Company is taking this action as a precautionary measure, because the products may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practice (cGMP).

Patients who may have these products in their possession should continue to take them in accordance with their prescriptions, as the risk of suddenly stopping needed medications may place patients at risk. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these products, or to obtain replacement medications or prescriptions.

Products Recalled to the Wholesale/Distributor Level:

Prescription Prenatal Vitamin Products:

Advanced NatalCare® Tablets

Advanced-RF NatalCare® Tablets

Cal-Nate™ Tablets

CareNatal™ DHA Tablets

ComBgen Tablets

ComBiRx™Tablets

NataCaps Capsules

NatalCare Gloss Tablets

NatalCare PIC Tablets

NatalCare PIC Forte Tablets

NatalCare Plus Tablets

NatalCare Rx Tablets

NatalCare Three Tablets

NataTab FA Tablets

NataTab RX Tablets

NutriNate® Chewable Tablets

NutriSpire™ Tablets

Prenatal MR 90 FE Tablets

Prenatal MTR w/Selinium Tablets

Prenatal Rx 1 Tablets

Prenatal Z, Advanced Formula Tablets

Ultra NatalCare Tablets

Prescription Iron Supplement Products:

Anemagen Caplets

Anemagen Forte Caplets

Conison™ Capsules

Fe-Tinic™ 150 Forte Capsules

Any wholesaler inquiries related to this action should be addressed to ETHEX Customer Service at 1-800-748-1472, faxed to ETHEX Customer Service at 314-646-3788, or e-mailed to customer-service@ethex.com. Representatives are available Monday through Friday, 8 am to 5 pm CST.

ETHEX Corporation has initiated recall notifications to wholesalers nationwide who received any inventory of the recalled products, with instructions for returning the recalled products.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). At this time, the Company is unable to determine when distribution of these products will resume.

Patients with questions about the recall should call the telephone number above, or contact their healthcare providers. Any adverse reactions experienced with the use of these products should also be reported to FDA’s MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

The recall announcement is posted on www.kvpharmaceutical.com.

If you or a loved one have been injured by Ethex Morphine or Ethex Propafenone you may be entitled to compensation. Contact the attorneys of Ennis & Ennis, P.A. today for a free case evaluation by filling out the form on this page or calling the toll free number listed below. Our staff is standing by to answer any questions you may have about the Ethex Morphine Recall, Ethex Propafenone Recall, and potential Ethex Corporation lawsuits.